Session Information

  • WCLC 2020

    2020 World Conference on Lung Cancer

    Conference Program for the 2020 World Conference on Lung Cancer in Singapore


    Presentation Date(s):  
    • January 28 - 31, 2021
    • Total Presentations: 1597

    All times listed are in Singapore time (GMT+8)

    PL - Plenary
    PS - Presidential Symposium
    ES - Education Session
    OA - Oral Session
    MA - Mini Oral Session
    FP - Featured Posters
    P - Posters
    IS - Industry Symposium
    JICC - Joint IASLC-CAALC-CSCO Session

Filter Results:

Show Only CME Accredited Sessions

  • +

    IS12 - Industry Symposium Sponsored by: Boehringer Ingelheim: Know Your Patients With NSCLC

    • 13:00 - 14:00
    • 1/30/2021
    • Location: Industry Symposia Auditorium (via Industry Hub)
    • Not for CME Credit
    • Type: Industry Symposium
    • Track:
    • +

      IS12.01 - Introduction

      13:00 - 13:05  |  Presenter: David R. Gandara

      • Abstract

      No abstract available for this presentation

    • +

      IS12.02 - Know How to Test Your Patients

      13:05 - 13:15  |  Presenter: John R Gosney

      • Abstract

      No abstract available for this presentation

    • +

      IS12.03 - Know How to Sequence EGFR TKIS

      13:15 - 13:25  |  Presenter: Barbara Melosky

      • Abstract

      No abstract available for this presentation

    • +

      IS12.04 - Know Your Patients With Uncommon EGFR Mutations

      13:25 - 13:35  |  Presenter: Satoru Miura

      • Abstract

      No abstract available for this presentation

    • +

      IS12.05 - What’s Next for Treatment of Advanced Stage Squamous NSCLC

      13:35 - 13:45  |  Presenter: David R. Gandara

      • Abstract

      No abstract available for this presentation

    • +

      IS12.06 - Know What’s Next for Your Patients: Looking to the Future

      13:45 - 13:55  |  Presenter: David R. Gandara

      • Abstract

      No abstract available for this presentation

    • +

      IS12.07 - Closing

      13:55 - 14:00  |  Presenter: David R. Gandara

      • Abstract

      No abstract available for this presentation

  • +

    IS13 - Satellite CME Symposium by ACE Oncology: Hot Topics in the Management of Advanced Non-Small Cell Lung Cancer: Expert Insights on Recent Advances

    • 13:00 - 14:00
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • CME Accredited by Other Provider
    • Type: Satellite CME Symposia
    • Track:
    • +

      IS13.01 - Welcome, Introduction, and Interactive Quiz

      13:00 - 13:05  |  Presenter: Daniel SW Tan

      • Abstract

      No abstract available for this presentation

    • +

      IS13.02 - When Is the Right Time to Use NGS-Based Liquid Biopsy in Advanced NSCLC?

      13:05 - 13:20  |  Presenter: Herbert H Loong

      • Abstract

      No abstract available for this presentation

    • +

      IS13.03 - Integrating New Targeted Therapy for NSCLC With Rare Oncogenic Drivers Into Clinical Practice

      13:20 - 13:35  |  Presenter: Terufumi Kato

      • Abstract

      No abstract available for this presentation

    • +

      IS13.04 - Enhancing Immune Checkpoint Inhibition With Bifunctional Antibodies

      13:35 - 13:50  |  Presenter: Daniel SW Tan

      • Abstract

      No abstract available for this presentation

    • +

      IS13.05 - Quiz Questions Revisited and Q&A

      13:50 - 13:59

      • Abstract

      No abstract available for this presentation

    • +

      IS13.06 - Pearls for Practice

      13:59 - 14:00  |  Presenter: Daniel SW Tan

      • Abstract

      No abstract available for this presentation

  • +

    ES15 - Getting All NSCLCs Genotyped: How Can We Get to 100%?

    • 14:15 - 15:15
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      ES15.01 - Reflex Genotyping of Advanced NSCLC: The Benefits and the Barriers

      14:15 - 14:30  |  Presenter: Dara Aisner

      • Abstract

      No abstract available for this presentation

    • +

      ES15.02 - Supplementing Tumor Genotyping with ctDNA Genotyping: What Is the Best Approach?

      14:30 - 14:45  |  Presenter: Fernando Lopez-Rios

      • Abstract

      No abstract available for this presentation

    • +

      ES15.04 - Engaging Lung Cancer Patients in their Molecular Testing

      14:45 - 15:00  |  Presenter: Andrew Ciupek

      • Abstract

      Loading...

    • +

      ES15.05 - Effective and Interpretable Reporting of Genotyping Results

      15:00 - 15:15  |  Presenter: Stacy Wang Gray

      • Abstract

      Loading...

  • +

    ES16 - Joint Global Lung Cancer Coalition/IASLC Session: Hot Topics for Advocates

    • 14:15 - 15:15
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Patient Advocacy
    • +

      ES16.01 - Chair

      14:15 - 14:15  |  Presenter: Matthew Peters

      • Abstract

      No abstract available for this presentation

    • +

      ES16.02 - Chair

      14:15 - 14:15  |  Presenter: Satoko Kono Yamaoka

      • Abstract

      No abstract available for this presentation

    • +

      ES16.03 - Pro – New Trend and Tool

      14:15 - 14:27  |  Presenter: Kazuo Hasegawa

      • Abstract

      No abstract available for this presentation

    • +

      ES16.04 - Campaigning for Lung Cancer Screening - A Tool for Advocates

      14:27 - 14:39  |  Presenter: Sarah Elizabeth Winstone

      • Abstract

      Loading...

    • +

      ES16.06 - Insights in Global Lung Cancer Patient Experience

      14:39 - 14:51  |  Presenter: Lillian Leigh

      • Abstract

      Loading...

    • +

      ES16.07 - Live Q&A

      14:51 - 15:15

      • Abstract

      No abstract available for this presentation

  • +

    MA06 - Molecular Developments and Novel Treatments in Mesothelioma and Thymoma

    • 14:15 - 15:15
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      MA06.01 - Chair

      14:15 - 14:15  |  Presenter: Harvey I. Pass

      • Abstract

      No abstract available for this presentation

    • +

      MA06.02 - Chair

      14:15 - 14:15  |  Presenter: Joachim Aerts

      • Abstract

      No abstract available for this presentation

    • +

      MA06.03 - Phosphorylated Ribosomal Protein S6, Correlation With Characteristics and Clinical Outcome in Patients With MPM: Results from ETOP Mesoscape

      14:15 - 14:20  |  Presenter: Isabelle Opitz

      • Abstract

      Loading...

    • +

      MA06.04 - FGF5 Expression in Malignant Pleural Mesothelioma: Impact on Cell Growth, Cisplatin Resistance and Patient Survival

      14:20 - 14:25  |  Presenter: Michael Grusch

      • Abstract

      Loading...

    • +

      MA06.05 - Targeting Anti-Apoptotic Mechanisms in Malignant Pleural Mesothelioma

      14:25 - 14:30  |  Presenter: Ren-Wang Peng

      • Abstract

      Loading...

    • +

      MA06.06 - Intracavitary Cisplatin-Fibrin followed by Irradiation after Lung Sparing Surgery in a Rat Model of Malignant Mesothelioma

      14:30 - 14:35  |  Presenter: Michaela B Kirschner

      • Abstract

      Loading...

    • +

      MA06.07 - Discussant

      14:35 - 14:40  |  Presenter: Rabab Mohamed Gaafar

      • Abstract

      No abstract available for this presentation

    • +

      MA06.08 - A Safety Study of Avelumab plus SBRT in Malignant Mesothelioma

      14:40 - 14:45  |  Presenter: Andreas Rimner

      • Abstract

      Loading...

    • +

      MA06.09 - Preliminary Safety, Efficacy Results of KN046 (Bispecific Anti-PD-L1/CTLA4) in Subjects With Rare Thoracic Tumors

      14:45 - 14:50  |  Presenter: Gary Richardson

      • Abstract

      Loading...

    • +

      MA06.10 - A New Horizon of Liquid Biopsy in Thymic Epithelial Tumors: The Potential Utility of Circulating Cell-Free DNA

      14:50 - 14:55  |  Presenter: Margaret Ottaviano

      • Abstract

      Loading...

    • +

      MA06.11 - The Collision of Good Syndrome and Autoimmunity in Thymic Epithelial Tumors

      14:55 - 15:00  |  Presenter: Giovannella Palmieri

      • Abstract

      Loading...

    • +

      MA06.12 - Discussant

      15:00 - 15:05  |  Presenter: Jan Hinrich von der Thüsen

      • Abstract

      No abstract available for this presentation

    • +

      MA06.13 - Live Q&A

      15:05 - 15:15

      • Abstract

      No abstract available for this presentation

  • +

    ES17 - The New WHO Classification of Lung Tumors

    • 15:30 - 16:30
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Pathology, Molecular Pathology and Diagnostic Biomarkers
    • +

      ES17.01 - Chair

      15:30 - 15:30  |  Presenter: Ming Sound Tsao

      • Abstract

      Loading...

    • +

      ES17.02 - Chair

      15:30 - 15:30  |  Presenter: Dong-Mei Lin

      • Abstract

      No abstract available for this presentation

    • +

      ES17.03 - Updates in Squamous Cell Carcinoma and Neuroendocrine Tumors of the Lung

      15:30 - 15:42  |  Presenter: Andrew Gordon Nicholson

      • Abstract

      Loading...

    • +

      ES17.04 - Updates in Mesothelioma

      15:42 - 15:54  |  Presenter: Sanja Dacic

      • Abstract

      Loading...

    • +

      ES17.05 - Updates in Lung Adenocarcinoma, Mucinous and Non-mucinous

      15:54 - 16:06  |  Presenter: Keith M Kerr

      • Abstract

      No abstract available for this presentation

    • +

      ES17.06 - Updates in Molecular Pathology and Genomics of Lung Tumors

      16:06 - 16:18  |  Presenter: Yasushi Yatabe

      • Abstract

      Loading...

    • +

      ES17.07 - Live Q&A

      16:18 - 16:30

      • Abstract

      No abstract available for this presentation

  • +

    MA07 - Improving Care for People with Lung Cancer: Decision Making, Survivorship, and New Challenges During COVID-19

    • 15:30 - 16:30
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Mini Oral
    • Track: Patient Advocacy
    • +

      MA07.01 - How Lung Cancer Patients Perceive their Treating Doctors and Engage in medical decision-making: Lessons from Project PRIORITY

      15:30 - 15:35  |  Presenter: Jill Feldman

      • Abstract

      Loading...

    • +

      MA07.02 - Are People with Lung Cancer Satisfied with the Care they Receive? 

      15:35 - 15:40  |  Presenter: Yvonne Nartey

      • Abstract

      Loading...

    • +

      MA07.03 - Current Practice of Lung Cancer Survivorship Care: Is a Care Plan Enough?

      15:40 - 15:45  |  Presenter: Hina Khan

      • Abstract

      Loading...

    • +

      MA07.04 - Breathe Anew: Designing and Testing the Feasibility of a Novel Intervention for Lung Cancer Survivorship

      15:45 - 15:50  |  Presenter: Yogita S Patel

      • Abstract

      Loading...

    • +

      MA07.05 - Survivors from Anti-PD-(L)1 Immunotherapy in NSCLC: Clinical Features, Survival Outcomes and Long-term Toxicities

      15:50 - 15:55  |  Presenter: Melinda Hsu

      • Abstract

      Loading...

    • +

      MA07.06 - Discussant

      15:55 - 16:07  |  Presenter: Haryana M. Dhillon

      • Abstract

      No abstract available for this presentation

    • +

      MA07.07 - Assessing the Impact of the COVID-19 Pandemic on Patient Advocacy and Support Organisations

      16:07 - 16:12  |  Presenter: Matthew Peters

      • Abstract

      Loading...

    • +

      MA07.08 - Needs Assessment of Lung Cancer Patients & Caregivers in the Post-Shelter-in-Place Era in the United States during COVID-19

      16:12 - 16:17  |  Presenter: Jessica Selig

      • Abstract

      Loading...

    • +

      MA07.09 - Lung Cancer Patients Survey Under COVID-19 Epidemic

      16:17 - 16:22  |  Presenter: Kazuo Hasegawa

      • Abstract

      Loading...

    • +

      MA07.10 - Discussant

      16:22 - 16:30  |  Presenter: Amy C. Moore

      • Abstract

      No abstract available for this presentation

  • +

    OA09 - Mesothelioma from Pathogenesis to Therapy

    • 15:30 - 16:30
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Oral
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      OA09.01 - Chair

      15:30 - 15:30  |  Presenter: Bruce Robinson

      • Abstract

      No abstract available for this presentation

    • +

      OA09.02 - Chair

      15:30 - 15:30  |  Presenter: Steven Kao

      • Abstract

      No abstract available for this presentation

    • +

      OA09.03 - MESOMICS Project: Molecular Characterization of Malignant Pleural Mesothelioma Using a Multi-Omic Approach

      15:30 - 15:40  |  Presenter: Lise Mangiante

      • Abstract

      Loading...

    • +

      OA09.04 - The Course of the Risk of Mesothelioma in Karain Cohort With Erionite Exposure Living in Stockholm: No Erionite Exposure No Mesothelioma

      15:40 - 15:50  |  Presenter: MUZAFFER METINTAS

      • Abstract

      Loading...

    • +

      OA09.05 - Real-World Survival Outcomes of Patients with Malignant Pleural Mesothelioma by Physician’s Choice of First-line Platinum Chemotherapy

      15:50 - 16:00  |  Presenter: Kathleen Claire Kerrigan

      • Abstract

      Loading...

    • +

      OA09.06 - Nivolumab in Recurrent Malignant Pleural Mesothelioma: Real-World Data From Expanded Access Program In The Netherlands

      16:00 - 16:10  |  Presenter: Robert Anton Belderbos

      • Abstract

      Loading...

    • +

      OA09.07 - Discussant

      16:10 - 16:20  |  Presenter: Thomas John

      • Abstract

      No abstract available for this presentation

    • +

      OA09.08 - Live Q&A

      16:20 - 16:30

      • Abstract

      No abstract available for this presentation

  • +

    ES18 - The Future of Immunotherapy in Unresectable Mesothelioma

    • 16:45 - 17:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Mesothelioma, Thymoma and Other Thoracic Malignancies
    • +

      ES18.01 - Immunotherapy – Current State of Play (Concentrating on Current Data for First Line and Salvage Strategies)

      16:45 - 17:00  |  Presenter: Sanjay Popat

      • Abstract

      Loading...

    • +

      ES18.02 - Molecular Profiling as Biomarker for Checkpoint Inhibitors in Mesothelioma

      17:00 - 17:15  |  Presenter: Nicola Jane Waddell

      • Abstract

      No abstract available for this presentation

    • +

      ES18.03 - Checkpoint Inhibitors – How to Combine and Which Combination is Most Promising

      17:15 - 17:30  |  Presenter: Anna Katherine Nowak

      • Abstract

      No abstract available for this presentation

    • +

      ES18.04 - BAP1 as a Biomarker - Implications for Treatment (Including Immunotherapy)

      17:30 - 17:45  |  Presenter: Michele Carbone

      • Abstract

      No abstract available for this presentation

  • +

    ES19 - Patient-Reported Outcomes, Patient Registries and Real-World Evidence: Learning Directly from Patients

    • 16:45 - 17:45
    • 1/30/2021
    • Location: Scientific Program Auditorium
    • IASLC CME Accredited
    • Type: Educational Session
    • Track: Patient Advocacy
    • +

      ES19.01 - Chair

      16:45 - 16:45  |  Presenter: Catherine Holliday

      • Abstract

      No abstract available for this presentation

    • +

      ES19.02 - Chair

      16:45 - 16:45  |  Presenter: Vanessa Beattie

      • Abstract

      No abstract available for this presentation

    • +

      ES19.03 - Understanding the Feasibility of Patient Reported Outcomes

      16:45 - 17:00  |  Presenter: Karla Gough

      • Abstract

      Loading...

    • +

      ES19.04 - Improving Lung Cancer Survival Through Tracking of Patient Reported Outcomes

      17:00 - 17:15  |  Presenter: Massimo Di Maio

      • Abstract

      Loading...

    • +

      ES19.05 - Incorporating Patient Reported Outcomes into the Lung Cancer Registry

      17:15 - 17:30  |  Presenter: Jennifer C. King

      • Abstract

      Loading...

    • +

      ES19.06 - Live Q&A

      17:30 - 17:45

      • Abstract

      No abstract available for this presentation